References
- Azadeh S, Moghimi-Dehkordi B, Fatem S, et al (2007). Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
- Boulay JL, Mild G, Lowy A, et al (2003). SMAD7 is a prognostic marker in patients with colorectal cancer. Int J Cancer, 104, 446-9. https://doi.org/10.1002/ijc.10908
- Broderick P, Carvajal-Carmona L, Pittman AM, et al (2007). A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nature Genetics, 39, 1315-7. https://doi.org/10.1038/ng.2007.18
-
Derynck R, Akhurst RJ, Balmain A (2001). TGF-
$\beta$ signaling in tumor suppression and cancer progression. Nature Genetics, 29, 117-29. https://doi.org/10.1038/ng1001-117 - Gaasenbeek M, Howarth K, Rowan AJ, et al (2006). Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res, 66, 3471-9. https://doi.org/10.1158/0008-5472.CAN-05-3285
- Green MR, Sambrook J (2012). Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press.
- Haerian MS, Haerian BS, Rooki H, et al (2014). Association of 8q24.21 rs10505477-rs6983267 haplotype and age at diagnosis of colorectal cancer. Asian Pac J Cancer Prev, 15, 369-74. https://doi.org/10.7314/APJCP.2014.15.1.369
- Haghighi MM, Vahedi M, Mohebbi SR, et al (2009). Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer. Asian Pac J Cancer Prev, 10, 497-500.
- Halder S, Rachakonda G, Deane N, et al (2008). SMAD7 induces hepatic metastasis in colorectal cancer. Br J Cancer, 99, 957-65. https://doi.org/10.1038/sj.bjc.6604562
-
Halder SK, Beauchamp RD, Datta PK (2005). SMAD7 induces tumorigenicity by blocking TGF-
$\beta$ -induced growth inhibition and apoptosis. Experimental Cell Res, 307, 231-46. https://doi.org/10.1016/j.yexcr.2005.03.009 - Hong S, Lim S, Li AG, et al (2007). SMAD7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nature Immunology, 8, 504-13. https://doi.org/10.1038/ni1451
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jiang X, Castelao JE, Vandenberg D, et al (2013). Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PloS one, 8, 60464. https://doi.org/10.1371/journal.pone.0060464
- Kirk BW, Feinsod M, Favis R, et al (2002). Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res, 30, 3295-311. https://doi.org/10.1093/nar/gkf466
- Levy L, Hill CS (2006). Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev, 17, 41-58. https://doi.org/10.1016/j.cytogfr.2005.09.009
- Li X, Yang X-x, Hu N-y, et al (2011). A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Molecular Biology Reports, 38, 5093-7. https://doi.org/10.1007/s11033-010-0656-3
- Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. New Eng J Med, 343, 78-85. https://doi.org/10.1056/NEJM200007133430201
-
Massague J (2008). TGF
$\beta$ in cancer. Cell, 134, 215-30. https://doi.org/10.1016/j.cell.2008.07.001 - Milanizadeh S, Khanyaghma M, Haghighi MM, et al (2013). Molecular analysis of imperative polymorphisms of MLH1 gene in sporadic colorectal cancer. Cancer Biomark, 13, 427-32.
- Moghimi-Dehkordi B, Safaee A (2012). An overview of colorectal cancer survival rates and prognosis in Asia. World J Gastrointestinal Oncol, 4, 71. https://doi.org/10.4251/wjgo.v4.i4.71
- Nassiri M, Kooshyar MM, Roudbar Z, et al (2013). Genes and SNPs associated with non-hereditary and hereditary colorectal cancer. Asian Pac J Cancer Prev, 14, 5609-14. https://doi.org/10.7314/APJCP.2013.14.10.5609
- Pittman AM, Naranjo S, Webb E, et al (2009). The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. Genome Res, 19, 987-93. https://doi.org/10.1101/gr.092668.109
- Rizzo A, Waldner MJ, Stolfi C, et al (2011). SMAD7 expression in T cells prevents colitis-associated cancer. Cancer Res, 71, 7423-32. https://doi.org/10.1158/0008-5472.CAN-11-1895
- Shemirani AI, Haghighi MM, Zadeh SM, et al (2011). Simplified MSI marker panel for diagnosis of colorectal cancer. Asian Pac J Cancer Prev, 12, 2101-4.
- Slattery ML, Herrick J, Curtin K, et al (2010). Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res, 70, 1479-85. https://doi.org/10.1158/0008-5472.CAN-08-1792
- Song Q, Zhu B, Hu W, et al (2012). A common SMAD7 variant is associated with risk of colorectal cancer: evidence from a case-control study and a meta-analysis. PloS One, 7, 33318. https://doi.org/10.1371/journal.pone.0033318
- Stolfi C, Marafini I, De Simone V, et al (2013). The dual role of SMAD7 in the control of cancer growth and metastasis. Int J Molecular Sci, 14, 23774-90. https://doi.org/10.3390/ijms141223774
- Tenesa A, Dunlop MG (2009). New insights into the aetiology of colorectal cancer from genome-wide association studies. Nature Reviews Genetics, 10, 353-8.
- Tenesa A, Farrington SM, Prendergast JG, et al (2008). Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genetics, 40, 631-7. https://doi.org/10.1038/ng.133
- Thompson CL, Plummer SJ, Acheson LS, et al (2009). Association of common genetic variants in SMAD7 and risk of colon cancer. Carcinogenesis, 30, 982-6. https://doi.org/10.1093/carcin/bgp086
- Tomlinson IP, Webb E, Carvajal-Carmona L, et al (2008). A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23. 3. Nature Genetics, 40, 623-30. https://doi.org/10.1038/ng.111
-
Xu Y, Pasche B (2007). TGF-
$\beta$ signaling alterations and susceptibility to colorectal cancer. Human Molecular Genetics, 16, 14-20. https://doi.org/10.1093/hmg/ddl486 - Yan X, Chen Y (2011). SMAD7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling. Biochem J, 434, 1-10. https://doi.org/10.1042/BJ20101827
Cited by
- Intronic Polymorphisms of the SMAD7 Gene in Association with Colorectal Cancer vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.41
- Molecular Biomarkers of Colorectal Cancer: A Review of Published Articles From Iran vol.3, pp.3, 2015, https://doi.org/10.17795/acr-30100